Blue Note Therapeutics Enters Licensing Agreement with University of Sydney for ConquerFear, a Cancer Survivorship Intervention
February 2022
In support of providing solutions to patients beyond active cancer treatment, Blue Note Therapeutics has entered into an exclusive licensing agreement for ConquerFear, an intervention to teach patients ways to cope with fear of cancer recurrence.
Read more →